ClearRead CT CAC

CE, FDA & Health Canada | Cardiac CT | CT | Amplifier Partner

Amplifier Marketplace Cardiology

Description of use

ClearRead™ CT CAC is part of the ClearRead CT cardiothoracic AI suite for pulmonary nodule detection and coronary artery calcification (CAC) scoring. A series of advanced AI algorithms are deployed that target complex and time-consuming conditions like lung cancer and coronary disease. ClearRead CT CAC leverages ungated, non-contrast chest CTs for the incidental detection and quantification of coronary artery calcification (CAC). It calculates an Agatston score and arterial age for a comprehensive cardiac risk assessment. Enjoy the proven accuracy, seamless workflow, and time-saving insights that ease cognitive burden and improve patient outcomes.

How is the application integrated?

Ask your Sectra representative which version of the Sectra PACS is compatible with the highlighted integration standards.

Contact us

Referring articles

The below are peer-reviewed articles that have been submitted by the AI vendor to serve as scientific validation of the application.

Other applications by this vendor

ClearRead™ Xray (Bone Suppress and Enhance)
FDA, CE & Health Canada | X-ray
ClearRead™ Xray improves reading efficiency and accuracy of chest radiographs, optimizing diagnostic value of portable and upright images. ClearRead Xray Bone Suppress increases visibility of soft tissue in chest radiographs, suppressing bone on the digital image, without the need for two exposures.
ClearRead™ CT
FDA, CE & Health Canada | CT
ClearRead CT improves nodule search efficiency and detection accuracy for all nodule types using patented vessel suppression technology. The application operates of contrast and non-contrast CTs.

Let’s talk

Are you interested in learning more? Please do not hesitate to get in touch with us at Sectra.

Contact us

The application content is provided by the respective AI vendors.